SynthesisJournal of medical virology2021
Obesity aggravates COVID-19: A systematic review and meta-analysis.
Synthesis in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 181 papers, 16 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
181 citing papers in PubMed, 16 syntheses or guidelines pooled it, 413 citations in OpenAlex.
- Prevalence of systemic complications of COVID-19 in critically ill patients: systematic review with meta-analysis.Revista latino-americana de enfermagem · 2025Pooled it
- Prevalence of obsessive-compulsive disorder in the older person: a systematic review and meta-analysis.BMC geriatrics · 2024Pooled it
- Global prevalence of gastric intestinal metaplasia: a systematic review and meta-analysis.Systematic reviews · 2024Pooled it
- Global prevalence of sexual dysfunction in cardiovascular patients: a systematic review and meta-analysis.Systematic reviews · 2024Pooled it
- Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic.European journal of internal medicine · 2023Pooled it
- The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis.Eating and weight disorders : EWD · 2022Pooled it
- Pooled it
- Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.BMC medicine · 2021Pooled it
- Obesity aggravates COVID-19: An updated systematic review and meta-analysis.Journal of medical virology · 2021Pooled it
- Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis.Metabolism: clinical and experimental · 2021Pooled it
- Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021Pooled it
- Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.Epidemiology and infection · 2021Pooled it
- Obesity aggravates COVID-19: A systematic review and meta-analysis.Journal of medical virology · 2021Pooled it
- Prevalence of Obesity and Its Impact on Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.Frontiers in endocrinology · 2021Pooled it
- A meta-analysis of the association between obesity and COVID-19.Epidemiology and infection · 2020Pooled it
- Obesity in patients with COVID-19: a systematic review and meta-analysis.Metabolism: clinical and experimental · 2020Pooled it
- Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS.Blood advances · 2023Trial
- Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia-a randomized controlled feeding trial.The American journal of clinical nutrition · 2022Trial
- Effects of a group-based weight management programme on anxiety and depression: A randomised controlled trial (RCT).PloS one · 2022Trial
- Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.RMD open · 2021Trial
121 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity and COVID-19 are both worldwide epidemics now. There may be some potential relationships between them, but little is known. This study was done to explore this relationship through literature search, systematic review, and meta-analysis. Pubmed, Embase, WOS, Cochrane, CNKI, Wanfang, and Sinomed databases were searched to collect literature concerning obesity and COVID-19. Systematic review and meta-analysis were conducted after literature screening, quality assessment, and data extraction. A total of 180 articles were initially searched after duplicate removal, and 9 were finally included in our analysis. Results show that severe COVID-19 patients have a higher body mass index than non-severe ones (WMD = 2.67; 95% CI, 1.52-3.82); COVID-19 patients with obesity were more severely affected and have a worse outcome than those without (OR = 2.31; 95% CI, 1.3-4.12). Obesity may aggravate COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.